Hepharm Sp. z o.o. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Secondary Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing | Other Chemical Product and Preparation Manufacturing | Other Miscellaneous Durable Goods Merchant Wholesalers | Miscellaneous Store Retailers | Other Direct Selling Establishments | Other Information Services | Scientific Research and Development Services | Research and Development in the Physical, Engineering, and Life Sciences

Full name: Hepharm Sp. z o.o.

Profile Updated: March 27, 2025

Hepharm Sp. z o.o. is based in Poland. The head office is in Pulawy. The enterprise operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. It was incorporated on December 13, 2016. 1 (2017) employees currently work for Hepharm Sp. z o.o.. The latest financial highlights indicate a net sales revenue drop of 25.13% in 2025. Its’ total assets recorded a negative growth of 0.77%. The net profit margin of Hepharm Sp. z o.o. increased by 1604.08% in 2025.

Headquarters
Ul. Marsz. Jozefa Pilsudskiego 57/1/2
Pulawy; Lubelskie; Postal Code: 24-100

Contact Details: Purchase the Hepharm Sp. z o.o. report to view the information.

Basic Information

Total Employees:

Purchase the Hepharm Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Hepharm Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Hepharm Sp. z o.o. report to view the information.

Incorporation Date:

December 13, 2016

Key Executives

Purchase this report to view the information.

President

Ownership Details

Purchase this report to view the information.

98%

Company Performance

Financial values in the chart are available after Hepharm Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

-25.13%▼

Total Operating Revenue

-21.93%▼

Operating Profit

99.32%▲

EBITDA

N/A

Net Profit/Loss for the Period

99.32%▲

Total Assets

-0.77%▼

Total Equity

-0.3%▼

Operating Profit Margin

1604.08%▲

Net Profit Margin

1604.08%▲

Return on Equity (ROE)

-44.03%▼

Similar companies